Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Bevacizumab for PDR with New Dense Vitreous Hemorrhage
NCT01724385Phase 4Completed
- Sponsor
- Khon Kaen University
- Start
- Aug 2012
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in proliferative diabetic retinopathy (PDR), Vitreous hemorrhage (VH), sponsored by Khon Kaen University. Started Aug 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)Vitreous hemorrhage (VH)
Beyond the preview
Go deeper on NCT01724385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724385.